Omeros (OMER) Other Non-Current Liabilities (2021 - 2026)

Omeros' (OMER) quarterly Other Non-Current Liabilities came in at $84.0 million in Q1 2026, up 1766.81% year-on-year from $4.5 million in Q1 2025, and up 1373.61% quarter-over-quarter from $5.7 million in Q4 2025.

Omeros (OMER) Other Non-Current Liabilities (2021 - 2026) Analysis & Trends

Omeros has disclosed Other Non-Current Liabilities across 6 years of filings, most recently posting $84.0 million for Q1 2026.

  • Other Non-Current Liabilities for Q1 2026 came in at $84.0 million, up 1766.81% year-over-year; the trailing twelve-month figure through Mar 2026 was $84.0 million (up 1766.81% YoY), and the FY2025 annual result was $5.7 million, up 26.68% from the prior year.
  • Other Non-Current Liabilities came in at $84.0 million for Q1 2026 at Omeros, up from $5.7 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $178.1 million in Q2 2025 to a low of $444000.0 in Q4 2022.
  • The 5-year median for Other Non-Current Liabilities is $2.1 million (2023), against an average of $27.7 million.
  • Across the five-year window, Other Non-Current Liabilities plunged 60.18% in 2022 and soared 8428.83% in 2025, its largest moves.
  • Omeros' Other Non-Current Liabilities stood at $444000.0 in 2022, then soared by 370.27% to $2.1 million in 2023, then soared by 115.57% to $4.5 million in 2024, then gained by 26.68% to $5.7 million in 2025, then soared by 1373.61% to $84.0 million in 2026.
  • The last three Other Non-Current Liabilities figures came in at $84.0 million (Q1 2026), $5.7 million (Q4 2025), and $152.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Omeros 737.87 Mn 602.55 Mn 9.31 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 84.03 Mn
Dec 31, 2025 5.70 Mn
Sep 30, 2025 152.53 Mn
Jun 30, 2025 178.08 Mn
Mar 31, 2025 4.50 Mn
Dec 31, 2024 4.50 Mn
Sep 30, 2024 3.09 Mn
Jun 30, 2024 2.09 Mn
Mar 31, 2024 2.09 Mn
Dec 31, 2023 2.09 Mn
Jun 30, 2023 496,000.00
Mar 31, 2023 452,000.00
Dec 31, 2022 444,000.00
Sep 30, 2022 999,000.00
Jun 30, 2022 961,000.00
Mar 31, 2022 922,000.00
Dec 31, 2021 1.12 Mn